Dietary Vitamin D Inadequacy Accelerates Calcification and Osteoblast-Like Cell Formation in the Vascular System of LDL Receptor Knockout and Wild-Type Mice
Abstract:Vitamin D insufficiency is highly associated with cardiovascular morbidity and mortality. We have demonstrated enhanced vascular calcification in LDL receptor knockout (LDLR(-/-)) mice fed a diet low in vitamin D. This study aimed to investigate the impact of a diet low in vitamin D on vascular calcification in wild-type (WT) mice lacking atherosclerotic plaques and the effects of a persistent and discontinuous vitamin D insufficiency on atherosclerotic plaque composition in LDLR(-/-) mice. The study was perfo… Show more
“…There is evidence from experimental studies that important cardiovascular risk factors such as vascular calcification, foam cell formation and macrophage cholesterol uptake may be suppressed by adequate vitamin D supply [5,6]. Deficient and insufficient vitamin D status, i.e.…”
“…There is evidence from experimental studies that important cardiovascular risk factors such as vascular calcification, foam cell formation and macrophage cholesterol uptake may be suppressed by adequate vitamin D supply [5,6]. Deficient and insufficient vitamin D status, i.e.…”
“…In addition, some micronutrient deficiencies may promote AC via this mechanism. Feeding mice with low vitamin D for 16 wk, Schmidt et al (89) observed more calcified spots in the aortic valve than those given adequate vitamin D, accompanied by higher expressions of BMP2 and Runx2. Similarly, in animal VSMCs calcification models, administration of Mg dose-dependently decreased expressions of BMP2, osteocalcin, and ALP, leading to amelioration of VSMCs calcification (44,70).…”
Section: The Possible Mechanisms For Mics-induced Ac In Ckdmentioning
In chronic kidney disease (CKD), simultaneous mineral and skeleton changes are prevalent, known as CKD-mineral bone disorder (CKD-MBD). Arterial calcification (AC) is a clinically important complication of CKD-MBD. It can increase arterial stiffness, which leads to severe cardiovascular events. However, current treatments have little effect on regression of AC, as its mechanisms are still unclear. There are multiple risk factors of AC, among which Malnutrition-Inflammation Complex Syndrome (MICS) is a new and crucial one. MICS, a combined syndrome of malnutrition and inflammation, generally begins at the early stage of CKD and becomes obvious in end-stage renal disease (ESRD). It was linked to reverse epidemiology and associated with increased cardiovascular mortality in ESRD patients. Recent data suggest that MICS can trigger CKD-MBD and accelerate the course of AC. In this present review, we summarize the recent understanding about the aggravating effects of MICS on AC and discuss the possible underlying mechanisms. A series of findings indicate that targeting MICS will provide a potential strategy for treating AC in CKD.
“…There are no human intake studies with respect to CV calcification, probably because dietary vitamin D provides only a relatively small contribution to serum 25(OH)D. Animal studies, however, show that high vitamin D intake can induce CV calcification and impair endothelial function 128,129 but they also show that a vitamin D deficient diet can induce an increase in calcified lesions [130][131][132] , indicating that both excess and deficiency are detrimental. Several epidemiological studies measuring serum 25(OH)D demonstrate an absence of association with presence or extent of CAC, MAC, cIMT, degree of carotid stenosis or mean arterial pressure 22,[133][134][135] , although patients with calcific aortic stenosis 136 and poor coronary collateral circulation 137 140 and with the calcification score in peripheral arterial disease 27 .…”
This comparison of the effects of calcium, phosphorus, magnesium and vitamin D on cardiovascular (CV) calcification and<br />bone has shown that in general the micronutrients that promote bone health also protect the arteries. We have shown that<br />adequate amounts of all three minerals should be ingested, paying particular attention to supplementing calcium to bind high<br />phosphorus and to ensure the maximum benefit from supplementing vitamin D. It appears that the optimum intake for bone is<br />>800 mg/d calcium, with postmenopausal women possibly requiring a total intake of >1100mg/d. Both CV and bone studies<br />suggest achieving a serum 25(OH)D level of >75nmol/l. These relationships are valid for a Caucasian population, however,<br />and may not hold in African Americans and Asians. The recent concerns that calcium supplementation may increase CV<br />disease risk has largely proved groundless, with higher calcium intake improving dyslipidaemia, hypertension and mortality.<br />With respect to higher serum phosphate, there is an association with CV calcification and CVD risk even within the normal<br />range, suggesting that the reference ranges may need to be redefined for ‘at risk’ patients. CV calcification was reduced in<br />CKD patients with magnesium intake in the range 384-669mg/d. When considering the complex interplay of the action of the<br />minerals together with their regulators vitamin D, PTH and FGF23, it is clear that this is a very sophisticated system which<br />attempts to maintain calcium homeostasis to the possible detriment of bone and arteries. This reinforces the need to ensure<br />adequate calcium intake before supplementing vitamin D.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.